Department of Ophthalmology, National Healthcare Group Eye Institute , Singapore, Singapore.
Singapore Eye Research Institute , Singapore, Singapore.
Ocul Immunol Inflamm. 2020 Jul 3;28(5):726-734. doi: 10.1080/09273948.2020.1772313. Epub 2020 Jun 16.
The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached pandemic proportions within an unprecedented span of time. It is controversial whether the virus can be transmitted via tears and its ocular implications have not been widely studied. In this article, the current evidence related to ocular transmission and ocular manifestations is reviewed.
Several mechanisms for the ocular transmission of the virus are proposed with highlight on the nasolacrimal system as a conduit between the eye and the respiratory tract, and the role of the lacrimal gland in hematogenous spread. Ocular surface manifestations such as conjunctivitis are more commonly reported.
The exact pathophysiology of ocular transmission of the virus remains incompletely understood, although there is preliminary evidence of SARS-CoV-2 being detected in ocular secretions. The ocular tropism of the virus and its potential to cause localized ocular disease are worth considering.
由严重急性呼吸系统综合征冠状病毒 2 型(SARS-CoV-2)引起的 2019 年冠状病毒病(COVID-19)疫情在空前的短时间内达到了大流行的程度。关于病毒是否可以通过眼泪传播以及其眼部影响尚未得到广泛研究,这存在争议。本文回顾了与病毒的眼部传播和眼部表现相关的现有证据。
提出了几种病毒的眼部传播机制,重点介绍了鼻泪管作为眼睛和呼吸道之间的通道,以及泪腺在血源性传播中的作用。更常报道的眼部表面表现为结膜炎。
尽管有初步证据表明在眼部分泌物中检测到 SARS-CoV-2,但病毒的眼部传播的确切病理生理学仍不完全清楚。病毒的眼部趋向性及其引起局部眼部疾病的潜力值得考虑。